Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.

Chen L, Wu YY, Liu P, Wang J, Wang G, Qin J, Zhou J, Zhu J.

Med Oncol. 2011 Dec;28 Suppl 1:S528-39. doi: 10.1007/s12032-010-9690-1. Epub 2011 Jan 11.

PMID:
21222176
2.

Bivalent HPV Recombinant Vaccine (Cervarix) for the Prevention of Cervical Cancer.

Schauner S, Lyon C.

Am Fam Physician. 2010 Dec 15;82(12):1541-2. Review. No abstract available.

4.

Human papillomavirus oncoproteins: pathways to transformation.

Moody CA, Laimins LA.

Nat Rev Cancer. 2010 Aug;10(8):550-60. doi: 10.1038/nrc2886. Epub 2010 Jul 1. Review.

PMID:
20592731
5.

Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo.

Wang W, Sima N, Kong D, Luo A, Gao Q, Liao S, Li W, Han L, Wang J, Wang S, Lu Y, Wang D, Xu G, Zhou J, Meng L, Ma D.

Cancer Lett. 2010 May 1;291(1):67-75. doi: 10.1016/j.canlet.2009.09.022. Epub 2009 Nov 10.

PMID:
19903581
6.

HPV E6 protein interacts physically and functionally with the cellular telomerase complex.

Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18780-5. doi: 10.1073/pnas.0906357106. Epub 2009 Oct 20.

7.

HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition.

Hellner K, Mar J, Fang F, Quackenbush J, Münger K.

Virology. 2009 Aug 15;391(1):57-63. doi: 10.1016/j.virol.2009.05.036. Epub 2009 Jun 23.

8.

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.

Rampias T, Sasaki C, Weinberger P, Psyrri A.

J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. doi: 10.1093/jnci/djp017. Epub 2009 Mar 10.

PMID:
19276448
9.

Senescence induction; a possible cancer therapy.

Lleonart ME, Artero-Castro A, Kondoh H.

Mol Cancer. 2009 Jan 8;8:3. doi: 10.1186/1476-4598-8-3. Review.

10.

Human papillomaviruses, cervical cancer and cell polarity.

Thomas M, Narayan N, Pim D, Tomaić V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L.

Oncogene. 2008 Nov 24;27(55):7018-30. doi: 10.1038/onc.2008.351. Review.

PMID:
19029942
11.

The human papillomavirus E7 oncoprotein.

McLaughlin-Drubin ME, Münger K.

Virology. 2009 Feb 20;384(2):335-44. doi: 10.1016/j.virol.2008.10.006. Epub 2008 Nov 12. Review.

12.

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.

Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr.

Gynecol Oncol. 2008 Nov;111(2):356-64. doi: 10.1016/j.ygyno.2008.06.033. Epub 2008 Aug 27.

PMID:
18755502
13.

Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.

Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC.

Cancer Cell. 2008 Jun;13(6):483-95. doi: 10.1016/j.ccr.2008.04.020.

14.

Anomalous features of EMT during keratinocyte transformation.

Geiger T, Sabanay H, Kravchenko-Balasha N, Geiger B, Levitzki A.

PLoS One. 2008 Feb 6;3(2):e1574. doi: 10.1371/journal.pone.0001574.

15.

Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.

Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.

Reprod Sci. 2007 Jan;14(1):20-8.

PMID:
17636212
17.

Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.

Au WW, Abdou-Salama S, Al-Hendy A.

Gynecol Oncol. 2007 Feb;104(2):276-80. Epub 2006 Nov 29.

18.

Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Wise-Draper TM, Allen HV, Jones EE, Habash KB, Matsuo H, Wells SI.

Mol Cell Biol. 2006 Oct;26(20):7506-19. Epub 2006 Aug 7.

19.

Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.

Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.

Int J Oncol. 2006 Sep;29(3):541-8.

PMID:
16865269
20.

Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes.

Karstensen B, Poppelreuther S, Bonin M, Walter M, Iftner T, Stubenrauch F.

Virology. 2006 Sep 15;353(1):200-9. Epub 2006 Jun 30.

Supplemental Content

Support Center